Nipro Corporation operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nipro with three other
medical equipment manufacturers in Asia:
JMS Co Ltd
sales of 55.57 billion Japanese Yen [US$500.17 million]
of which 68%
was Operating Segment-Japan),
Kawasumi Laboratories, Incorporated
(24.73 billion Japanese Yen [US$222.53 million]
of which 55%
was Extracorporeal Circulation-Related), and
(514.16 billion Japanese Yen [US$4.63 billion]
of which 51%
was Cardiovascular area business).
During the year ended March of 2017, sales at
Nipro were ¥359.70 billion (US$3.24 billion).
decrease of 1.9%
versus 2016, when the company's sales were ¥366.65 billion.
Contributing to the drop in overall sales was the 12.0% decline
in Glass-Related, from ¥32.18 billion to ¥28.33 billion.
There were also decreases in sales in
Medical Care (down 3.7% to ¥262.20 billion)
Other (down 9.4% to ¥29.00 million)
However, these declines were partially offset by the increase in sales of
Pharmaceutical Business (up 11.0% to ¥69.14 billion)